Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Steroid Withdrawal in Pediatric Kidney Transplant Recipients

ClinicalTrials.gov ID: NCT00023244

Public ClinicalTrials.gov record NCT00023244. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind Randomized Trial of Steroid Withdrawal in Sirolimus- and Cyclosporine-Treated Primary Transplant Recipients

Study identification

NCT ID
NCT00023244
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
274 participants

Conditions and interventions

Interventions

  • Bactrim Drug
  • Basiliximab Drug
  • Cyclosporine Drug
  • Methylprednisolone Drug
  • Prednisone Drug
  • Sirolimus Drug
  • Tacrolimus Drug

Drug

Eligibility (public fields only)

Age range
1 Day to 20 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2000
Primary completion
May 31, 2005
Completion
May 31, 2005
Last update posted
Oct 20, 2016

2001 – 2005

United States locations

U.S. sites
18
U.S. states
16
U.S. cities
17
Facility City State ZIP Site status
University of Alabama Birmingham Alabama 35233
UCSD Medical Center San Diego California 92103
Denver Children's Hospital Aurora Colorado 80045
University of Florida Health Science Center Jacksonville Florida 32209
Emory Children's Center Atlanta Georgia 30322
Tulane University Medical Center New Orleans Louisiana 70112
University of Maryland Medical Center Baltimore Maryland 21201
Children's Hospital of Boston Boston Massachusetts 02115
University of New Mexico Health Science Center Albuquerque New Mexico 87131
The Children's Hospital of Buffalo Buffalo New York 14222
Westchester Medical Center Valhalla New York 10595
Rainbow Babies and Childrens Hospital Cleveland Ohio 44106
University Hospitals of Cleveland Cleveland Ohio 44106
Penn State College of Medicine Hershey Pennsylvania 17033
LeBonheur Children's Medical Center Memphis Tennessee 38103
Christopher Goldsbury Center San Antonio Texas 78207
Children's Hospital and Regional Medical Center Seattle Washington 98105
University of Wisconsin Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00023244, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 20, 2016 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00023244 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →